Nurix Therapeutics Competitors and Similar CompaniesClear all

Nurix Therapeutics's competitors and similar companies include Foghorn Therapeutics, ImmunoTek, LifeNet Health and Glenmark Pharmaceuticals.

	Nurix Therapeutics Nurix Therapeutics is a clinical-stage biopharmaceutical company.	Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.	ImmunoTek ImmunoTek is a provider of healthcare services.	LifeNet Health LifeNet Health is a provider of transplant solutions.	Glenmark Pharmaceuticals Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations.
Founding Date	Founding Date 2012	Founding Date 2016	Founding Date 2012	Founding Date 1982	Founding Date 1977
Type	Type Public	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech drug development	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech	Tags Healthcare biotech medical devices	Tags Healthcare biotech pharma
Locations	Locations San Francisco, US HQ	Locations Cambridge, US HQ Cambridge, US	Locations Lafayette, US HQ	Locations Virginia Beach, US HQ Wien, AT Billings, US Durham, US Indianapolis, US Jacksonville, US Missoula, US see more	Locations Mumbai, IN HQ Mumbai, IN
Employees	Employees 3344% increase	Employees 1123% decrease	Employees 493	Employees 1,3132% increase	Employees 14,989
Financial
Revenue (est.)	Revenue (est.) $84m (FY, 2025)	Revenue (est.) $30.9m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $598.6m (FY, 2024)	Revenue (est.) ₹131.5b (FY, 2025)
Net income	Net income ($264.5m) (FY, 2025)	Net income ($74.4m) (FY, 2025)	Net income N/A	Net income $18m (FY, 2024)	Net income ₹10.5b (FY, 2025)
Funding
Total funding raised	Total funding raised $ 165.2m	Total funding raised $ 50m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A